AASLD's three practice guidelines on Non-Invasive Liver Disease Assessment (NILDA) are available for public comment through 1/2/24.
The draft guidelines are included in three guideline documents expected to be published in early 2024:
- AASLD Practice Guideline: Blood-Based Non-invasive Liver Disease Assessment of Hepatic Fibrosis and Steatosis. You can provide your comments on this document here: https://wkf.ms/48tGJO5
- AASLD Practice Guideline: Imaging-Based Non-Invasive Liver Disease Assessments of Hepatic Fibrosis and Steatosis. You can provide your comments on this document here: https://wkf.ms/48aMW1G
- AASLD Practice Guideline: Non-Invasive Liver Disease Assessments of Portal Hypertension. You can provide your comments on this document here: https://wkf.ms/3TCUDJK
AASLD welcomes stakeholders to review draft guidelines before finalization and publication. Although feedback received during the open comment period will be reviewed by the writing group and is advisory, AASLD will not respond to reviewers.
We appreciate your comments!